scispace - formally typeset
A

Arduino A. Mangoni

Researcher at Flinders Medical Centre

Publications -  397
Citations -  10350

Arduino A. Mangoni is an academic researcher from Flinders Medical Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 42, co-authored 348 publications receiving 7835 citations. Previous affiliations of Arduino A. Mangoni include University of Cambridge & King's College London.

Papers
More filters
Journal ArticleDOI

Effects of Isolated Systolic Hypertension and Essential Hypertension on Large and Middle-sized Artery Compliance

TL;DR: In systolic hypertension of the elderly the reduction of arterial Compliance is marked in both muscular and large elastic arteries, while in elderly essential hypertensives changes in arterial compliance are more heterogeneous, i.e. only carotid artery compliance is reduced.
Journal ArticleDOI

Cardiac and vascular structural changes in normotensive subjects with parental hypertension.

TL;DR: Parental predisposition to hypertension is accompanied by cardiac and arteriolar structural changes qualitatively similar to those found in hypertensive patients, although arteriolars structural changes do not involve all vascular beds.
Journal ArticleDOI

Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board

TL;DR: Proton‐pump inhibitors (PPI) are extensively prescribed worldwide, but little information is available on PPI prescribing patterns, associated clinical and demographic factors, and potential drug–drug interactions in frail older patients.
Journal ArticleDOI

The Second Life of Methylarginines as Cardiovascular Targets.

TL;DR: This review discusses the latest discoveries and controversies in the field and proposes novel directions for targeting methylarginines in clinical settings.
Journal ArticleDOI

Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.

TL;DR: SAA concentrations were significantly and positively associated with higher COVID-19 severity and mortality, and this acute phase reactant might assist with risk stratification and monitoring in this group.